Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 3Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 37Urinary Bladder Neoplasms 12Breast Neoplasms 7Neoplasms 6Kidney Neoplasms 5Carcinoma, Renal Cell 5Adenocarcinoma 5Carcinoma, Transitional Cell 4Stomach Neoplasms 3Ovarian Neoplasms 3Lung Neoplasms 3Heart Failure 3Disease 3Colorectal Neoplasms 3Anxiety Disorders 3Triple Negative Breast Neoplasms 2Pulmonary Disease, Chronic Obstructive 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Failure, Chronic 2Kidney Diseases 2Hematologic Neoplasms 2Cardiovascular Diseases 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Asthma 2von Hippel-Lindau Disease 1the Detection of Prostate Cancer in Men 1Uterine Cervical Neoplasms 1

Interventions

sacituzumab govitecan 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1avelumab 1Vinblastine 1Paclitaxel 1Nivolumab 1Methotrexate 1Gemcitabine 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Muscle Invasive Bladder Urothelial Carcinoma × Genitourinary × Clear all
NCT06204614 2026-05-18

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡